GlassScriptPhysician profile
Max Keeling
NPI 1508494089
$9,749.61
in general payments reported to CMS, 2019-2025
17 companies · $6,680 in 2025
The $6,680 reported for 2025 was more than what 99% of Emergency Medical Services providers received nationally (typical 2025 total: $70.35).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $91.53 · 2023: $95.35 · 2024: $2,883 · 2025: $6,680.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,405 · Travel and Lodging: $4,253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,404.61 |
| Travel and Lodging | $4,253.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,069.42 | 2024-2025 | Proclaim, Eterna, Durata |
| Boston Scientific Corporation | $2,098.90 | 2024-2025 | Intracept, Wavewriter Alpha Prime 16, General - Pain Management |
| Medtronic, INC. | $1,038.28 | 2024-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Kyphon Express II Kyphopak Tray |
| Nevro Corp. | $478.67 | 2024 | Senza |
| Stryker Corporation | $402.48 | 2025 | Mild Device Kit, Augment Injectable |
| Nalu Medical, INC. | $128.23 | 2025 | Nalu Neurostimulation System |
| Spinal Simplicity, LLC | $102.38 | 2024 | Ha Minuteman G3-R |
| Fisher & Paykel Healthcare INC | $95.35 | 2023 | Fisher & Paykel Healthcare |
| Vapotherm INC | $91.53 | 2022 | |
| Averitas Pharma INC. | $61.07 | 2025 | Qutenza |
| Si-Bone, INC. | $37.96 | 2025 | |
| Avanos Medical | $34.33 | 2024 | Coolief* Cooled Radiofrequency |
| Mml US, INC. | $30.26 | 2025 | Reactiv8 |
| Globus Medical, INC. | $25.95 | 2025 | Vyrsa V1 |
| Axsome Therapeutics, INC. | $21.69 | 2025 | Symbravo |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $19.49 | 2024 | Insorb |
| Abbvie INC. | $13.62 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Max Keeling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.